ScienceDex / Researcher record
Acharya, Suchismita
- Ayuvis Research, Inc. (no department on record)
- University of North Texas Health Science Center (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #5,549
- R01 Holder
- Diverse Portfolio
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2017 | $273,826 | 1 | #28,243 |
| 2020 | $365,000 | 1 | #15,413 |
| 2021 | $505,758 | 2 | #21,499 |
| 2022 | $1,468,034 | 2 | #5,839 |
| 2023 | $1,546,851 | 4 | #5,549 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20171 record
- FY20201 record
- FY20212 records
- FY20222 records
- FY2023 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Acharya, Suchismita as a PI. Multi-PI records show the full award amount for context.
- 5R44HD107857-02R44Contact PIA novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants$702.1Kaward amount
- 5R01EY029823-04R01Contact PINovel hybrid molecule with both IOP lowering and neuroprotective effects for treatment of glaucoma$370Kaward amount
- 1R61HL164372-01A1R61Contact PIPhase-1 Healthy adult human safety and pharmacokinetic study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in at-risk pre-term infants$270.8Kaward amount
- 3R44HD107857-02S1R44Contact PIA novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants$204Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Acharya, Suchismita as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardAyuvis Research, Inc.
- 2020$500K Cumulative Funding
- 2020Multi-Institutional ResearchAwards at 2 institutions
- 2020R01 Grant Holder
- 2021$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #5839